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Two dimensional (2-D) cell culture technologies have proven inadequate for large scale manufacturing to meet 
the anticipated commercial demands for cell therapy products. Growing cells on microcarriers suspended in 
bioreactors is considered a viable option for scaling up the manufacturing process. However, the commonly 
used cylindrical bioreactors with horizontal impellers require relatively high agitation power in order to fully 
suspend microcarriers, which can cause hydrodynamic stress to the cells in the culture fluid. Anchorage 
dependent cells grown on microcarriers are known to be more sensitive to hydrodynamic shear stress than 
suspended single cell cultures. In addition, the cells respond to their growth environment in ways that may affect 
product quality and potency. Combination of these facts makes it more challenging to identify the acceptable 
range of agitation rates to achieve satisfactory cell growth and quality attributes, and this problem becomes 
worse as the size of bioreactor increases. A single-use bioreactor system using an innovative Vertical-Wheel 
technology is recently introduced which promotes efficient, homogenous liquid mixing and uniform microcarrier 
suspension with low power input. Physical measurement of the minimum power levels required for 
homogeneous suspension of microcarriers and computational fluid dynamic analysis, indicate that the vertical 
mixing mechanism not only requires very low power input to fully suspend microcarriers, but also the low shear 
environment remains constant across the full range of vessel sizes from 0.5 to 50 liters. This unique 
characteristic of the vertical mixing mechanism offers unparalleled scalability to achieve a consistent and robust 
manufacturing process for shear sensitive cellular therapy products. The Vertical-Wheel single-use 
bioreactors have been evaluated with several different cell types including human bone marrow-derived 
mesenchymal stem cells (BM-MSC), human Chondrocytes, embryonic and induced pluripotent stem cells 
(PSC’s). The results of physical measurements of Kolmogorov scales, the growth of various types of cells, and 
the differentiation kinetics of PSC’s in various sizes of Vertical-Wheel bioreactors will be discussed. 
 
